MAZE logo

Maze Therapeutics, Inc. (MAZE) Depreciation and amortization

annual D&A:

$3.30M-$792.00K(-19.37%)
December 31, 2024

Summary

  • As of today (September 16, 2025), MAZE annual depreciation & amortization is $3.30 million, with the most recent change of -$792.00 thousand (-19.37%) on December 31, 2024.
  • During the last 3 years, MAZE annual D&A has fallen by -$523.00 thousand (-13.69%).
  • MAZE annual D&A is now -19.37% below its all-time high of $4.09 million, reached on December 31, 2023.

Performance

MAZE Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

quarterly D&A:

$649.00K-$35.00K(-5.12%)
June 30, 2025

Summary

  • As of today (September 16, 2025), MAZE quarterly depreciation & amortization is $649.00 thousand, with the most recent change of -$35.00 thousand (-5.12%) on June 30, 2025.
  • Over the past year, MAZE quarterly D&A has dropped by -$205.00 thousand (-24.00%).
  • MAZE quarterly D&A is now -79.15% below its all-time high of $3.11 million, reached on September 1, 2023.

Performance

MAZE quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

TTM D&A:

$2.04M-$205.00K(-9.14%)
June 30, 2025

Summary

  • As of today (September 16, 2025), MAZE TTM depreciation & amortization is $2.04 million, with the most recent change of -$205.00 thousand (-9.14%) on June 30, 2025.
  • Over the past year, MAZE TTM D&A has dropped by -$3.85 million (-65.42%).
  • MAZE TTM D&A is now -65.42% below its all-time high of $5.89 million, reached on June 30, 2024.

Performance

MAZE TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

MAZE Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-19.4%-24.0%-65.4%
3 y3 years-13.7%-79.2%-34.5%
5 y5 years-13.7%-79.2%-34.5%

MAZE Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-19.4%at low-79.2%at low-65.4%at low
5 y5-year-19.4%at low-79.2%at low-65.4%at low
alltimeall time-19.4%at low-79.2%at low-65.4%at low

MAZE Depreciation and amortization History

DateAnnualQuarterlyTTM
Jun 2025
-
$649.00K(-5.1%)
$2.04M(-9.1%)
Mar 2025
-
$684.00K(-3.0%)
$2.24M(-10.6%)
Dec 2024
$3.30M
$705.00K(-17.4%)
$2.51M(-57.4%)
Jun 2024
-
$854.00K(-10.1%)
$5.89M(+16.9%)
DateAnnualQuarterlyTTM
Mar 2024
-
$950.00K(-2.7%)
$5.04M(+23.2%)
Dec 2023
$4.09M(+7.0%)
$976.00K(-68.6%)
$4.09M(+31.4%)
Sep 2023
-
$3.11M
$3.11M
Dec 2022
$3.82M
-
-

FAQ

  • What is Maze Therapeutics, Inc. annual depreciation & amortization?
  • What is the all time high annual D&A for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. annual D&A year-on-year change?
  • What is Maze Therapeutics, Inc. quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. quarterly D&A year-on-year change?
  • What is Maze Therapeutics, Inc. TTM depreciation & amortization?
  • What is the all time high TTM D&A for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. TTM D&A year-on-year change?

What is Maze Therapeutics, Inc. annual depreciation & amortization?

The current annual D&A of MAZE is $3.30M

What is the all time high annual D&A for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high annual depreciation & amortization is $4.09M

What is Maze Therapeutics, Inc. annual D&A year-on-year change?

Over the past year, MAZE annual depreciation & amortization has changed by -$792.00K (-19.37%)

What is Maze Therapeutics, Inc. quarterly depreciation & amortization?

The current quarterly D&A of MAZE is $649.00K

What is the all time high quarterly D&A for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high quarterly depreciation & amortization is $3.11M

What is Maze Therapeutics, Inc. quarterly D&A year-on-year change?

Over the past year, MAZE quarterly depreciation & amortization has changed by -$205.00K (-24.00%)

What is Maze Therapeutics, Inc. TTM depreciation & amortization?

The current TTM D&A of MAZE is $2.04M

What is the all time high TTM D&A for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high TTM depreciation & amortization is $5.89M

What is Maze Therapeutics, Inc. TTM D&A year-on-year change?

Over the past year, MAZE TTM depreciation & amortization has changed by -$3.85M (-65.42%)
On this page